Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS
10.1038/nm1207
Crossref journal-article
Springer Science and Business Media LLC
Nature Medicine (297)
Bibliography

Raoul, C., Abbas-Terki, T., Bensadoun, J.-C., Guillot, S., Haase, G., Szulc, J., Henderson, C. E., & Aebischer, P. (2005). Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nature Medicine, 11(4), 423–428.

Authors 8
  1. Cédric Raoul (first)
  2. Toufik Abbas-Terki (additional)
  3. Jean-Charles Bensadoun (additional)
  4. Sandrine Guillot (additional)
  5. Georg Haase (additional)
  6. Jolanta Szulc (additional)
  7. Christopher E Henderson (additional)
  8. Patrick Aebischer (additional)
References 30 Referenced 364
  1. Bruijn, L.I., Miller, T.M. & Cleveland, D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27, 723–749 (2004). (10.1146/annurev.neuro.27.070203.144244) / Annu. Rev. Neurosci. by LI Bruijn (2004)
  2. Howland, D.S. et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. USA 99, 1604–1609 (2002). (10.1073/pnas.032539299) / Proc. Natl. Acad. Sci. USA by DS Howland (2002)
  3. Nagai, M. et al. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J. Neurosci. 21, 9246–9254 (2001). (10.1523/JNEUROSCI.21-23-09246.2001) / J. Neurosci. by M Nagai (2001)
  4. Newbery, H.J. & Abbott, C.M. Of mice, men and motor neurons. Trends Genet. 17, S2–S6 (2001). (10.1016/S0168-9525(01)02459-3) / Trends Genet. by HJ Newbery (2001)
  5. Dykxhoorn, D.M., Novina, C.D. & Sharp, P.A. Killing the messenger: short RNAs that silence gene expression. Nat. Rev. Mol. Cell Biol. 4, 457–467 (2003). (10.1038/nrm1129) / Nat. Rev. Mol. Cell Biol. by DM Dykxhoorn (2003)
  6. Abbas-Terki, T., Blanco-Bose, W., Deglon, N., Pralong, W. & Aebischer, P. Lentiviral-mediated RNA interference. Hum. Gene Ther. 13, 2197–2201 (2002). (10.1089/104303402320987888) / Hum. Gene Ther. by T Abbas-Terki (2002)
  7. Brummelkamp, T.R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550–553 (2002). (10.1126/science.1068999) / Science by TR Brummelkamp (2002)
  8. Ding, H. et al. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2, 209–217 (2003). (10.1046/j.1474-9728.2003.00054.x) / Aging Cell by H Ding (2003)
  9. Elbashir, S.M., Martinez, J., Patkaniowska, A., Lendeckel, W. & Tuschl, T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20, 6877–6888 (2001). (10.1093/emboj/20.23.6877) / EMBO J. by SM Elbashir (2001)
  10. Wiznerowicz, M. & Trono, D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 77, 8957–8961 (2003). (10.1128/JVI.77.16.8957-8951.2003) / J. Virol. by M Wiznerowicz (2003)
  11. Gurney, M.E. et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772–1775 (1994). (10.1126/science.8209258) / Science by ME Gurney (1994)
  12. Vila, M. & Przedborski, S. Targeting programmed cell death in neurodegenerative diseases. Nat. Rev. Neurosci. 4, 365–375 (2003). (10.1038/nrn1100) / Nat. Rev. Neurosci. by M Vila (2003)
  13. Raoul, C. et al. Motoneuron death triggered by a specific pathway downstream of Fas. Potentiation by ALS-linked SOD1 mutations. Neuron 35, 1067–1083 (2002). (10.1016/S0896-6273(02)00905-4) / Neuron by C Raoul (2002)
  14. Gong, Y.H., Parsadanian, A.S., Andreeva, A., Snider, W.D. & Elliott, J.L. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J. Neurosci. 20, 660–665 (2000). (10.1523/JNEUROSCI.20-02-00660.2000) / J. Neurosci. by YH Gong (2000)
  15. Clement, A.M. et al. Wild-type nonneuronal cells extent survival of SOD1 mutant motor neurons in ALS mice. Science 302, 113–117 (2003). (10.1126/science.1086071) / Science by AM Clement (2003)
  16. Guillot, S., Azzouz, M., Deglon, N., Zurn, A. & Aebischer, P. Local GDNF expression mediated by lentiviral vector protects facial nerve motoneurons but not spinal motoneurons in SOD1(G93A) transgenic mice. Neurobiol. Dis. 16, 139–149 (2004). (10.1016/j.nbd.2004.01.017) / Neurobiol. Dis. by S Guillot (2004)
  17. Azzouz, M. et al. Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno-associated virus encoding Bcl-2. Hum. Mol. Genet. 9, 803–811 (2000). (10.1093/hmg/9.5.803) / Hum. Mol. Genet. by M Azzouz (2000)
  18. Finger, S., Heavens, R.P., Sirinathsinghji, D.J., Kuehn, M.R. & Dunnett, S.B. Behavioral and neurochemical evaluation of a transgenic mouse model of Lesch-Nyhan syndrome. J. Neurol. Sci. 86, 203–213 (1988). (10.1016/0022-510X(88)90099-8) / J. Neurol. Sci. by S Finger (1988)
  19. Carter, R.J. et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 19, 3248–3257 (1999). (10.1523/JNEUROSCI.19-08-03248.1999) / J. Neurosci. by RJ Carter (1999)
  20. Kaspar, B.K., Llado, J., Sherkat, N., Rothstein, J.D. & Gage, F.H. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301, 839–842 (2003). (10.1126/science.1086137) / Science by BK Kaspar (2003)
  21. Azzouz, M. et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429, 413–417 (2004). (10.1038/nature02544) / Nature by M Azzouz (2004)
  22. Lino, M.M., Schneider, C. & Caroni, P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J. Neurosci. 22, 4825–4832 (2002). (10.1523/JNEUROSCI.22-12-04825.2002) / J. Neurosci. by MM Lino (2002)
  23. Al-Chalabi, A. et al. Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor. Hum. Mol. Genet. 7, 20452050 (1998). (10.1093/hmg/7.13.2045) / Hum. Mol. Genet. by A Al-Chalabi (1998)
  24. Wong, P.C. et al. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc. Natl. Acad. Sci. USA 97, 2886–2891 (2000). (10.1073/pnas.040461197) / Proc. Natl. Acad. Sci. USA by PC Wong (2000)
  25. Reaume, A.G. et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 13, 43–47 (1996). (10.1038/ng0596-43) / Nat. Genet. by AG Reaume (1996)
  26. Zeitlin, S., Liu, J.P., Chapman, D.L., Papaioannou, V.E. & Efstratiadis, A. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat. Genet. 11, 155–163 (1995). (10.1038/ng1095-155) / Nat. Genet. by S Zeitlin (1995)
  27. Elbashir, S.M., Harborth, J., Weber, K. & Tuschl, T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26, 199–213 (2002). (10.1016/S1046-2023(02)00023-3) / Methods by SM Elbashir (2002)
  28. Khvorova, A., Reynolds, A. & Jayasena, S.D. Functional siRNAs and miRNAs exhibit strand bias. Cell 115, 209–216 (2003). (10.1016/S0092-8674(03)00801-8) / Cell by A Khvorova (2003)
  29. Dull, T. et al. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463–8471 (1998). (10.1128/JVI.72.11.8463-8471.1998) / J. Virol. by T Dull (1998)
  30. Deglon, N. et al. Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum. Gene Ther. 11, 179–190 (2000). (10.1089/10430340050016256) / Hum. Gene Ther. by N Deglon (2000)
Dates
Type When
Created 20 years, 5 months ago (March 14, 2005, 12:36 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 6:18 p.m.)
Indexed 1 day, 14 hours ago (Sept. 3, 2025, 6:33 a.m.)
Issued 20 years, 5 months ago (March 13, 2005)
Published 20 years, 5 months ago (March 13, 2005)
Published Online 20 years, 5 months ago (March 13, 2005)
Published Print 20 years, 5 months ago (April 1, 2005)
Funders 0

None

@article{Raoul_2005, title={Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS}, volume={11}, ISSN={1546-170X}, url={http://dx.doi.org/10.1038/nm1207}, DOI={10.1038/nm1207}, number={4}, journal={Nature Medicine}, publisher={Springer Science and Business Media LLC}, author={Raoul, Cédric and Abbas-Terki, Toufik and Bensadoun, Jean-Charles and Guillot, Sandrine and Haase, Georg and Szulc, Jolanta and Henderson, Christopher E and Aebischer, Patrick}, year={2005}, month=mar, pages={423–428} }